Oxidation-strengthened disulfide-bridged prodrug nanoplatforms with cascade facilitated drug release for synergetic photochemotherapy

One of the major barriers in utilizing prodrug nanocarriers for cancer therapy is the slow release of parent drug in tumors. Tumor cells generally display the higher oxidative level than normal cells, and also displayed the heterogeneity in terms of redox homeostasis level. We previously found that...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Bin, Wei, Lin, Wang, Yuequan, Li, Na, Ji, Bin, Wang, Kaiyuan, Zhang, Xuanbo, Zhang, Shenwu, Zhou, Shuang, Yao, Xiaohui, Song, Hang, Wu, Yusheng, Zhang, Haotian, Kan, Qiming, Jin, Tao, Sun, Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shenyang Pharmaceutical University 2020
Materias:
Original Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7610204/
https://www.ncbi.nlm.nih.gov/pubmed/33193865
http://dx.doi.org/10.1016/j.ajps.2019.09.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7610204/
https://www.ncbi.nlm.nih.gov/pubmed/33193865
http://dx.doi.org/10.1016/j.ajps.2019.09.001

Ejemplares similares